---
schema_version: "secwatch.filing_event.v1"
accession: "0000950157-21-001239"
form_type: "8-K"
ticker: "TMO"
cik: "0000097745"
company_name: "THERMO FISHER SCIENTIFIC INC."
filed_at: "2021-12-08T23:59:59+00:00"
generated_at: "2026-06-28T02:59:35.138256+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Thermo Fisher completes $17.4B acquisition of clinical research firm PPD, Inc.

## Summary
- Total consideration $17.4 billion; PPD common stock ceased trading on Nasdaq.
- Deal expected to contribute $1.50 to Thermo Fisher's adjusted EPS in 2022.
- Synergies of ~$125M by year three: $75M cost, $50M revenue-related.
- Thermo Fisher assumes ~$3.0B net debt of PPD, all retired at closing.
- PPD to join Laboratory Products and Services Segment.

## SEC filing metadata
- accession: 0000950157-21-001239
- form_type: 8-K
- ticker: TMO
- cik: 0000097745
- company_name: THERMO FISHER SCIENTIFIC INC.
- filed_at: 2021-12-08T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/97745/000095015721001239/0000950157-21-001239-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/97745/000095015721001239/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950157-21-001239
- JSON: https://secwatch.observer/filing/0000950157-21-001239.json
- Plain text: https://secwatch.observer/filing/0000950157-21-001239.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.